Zimmermann E, Müller R H, Mäder K
Department of Pharmaceutics, Biopharmaceutics and Biotechnology, The Free University of Berlin, Kelchstr. 31, D-12169, Berlin, Germany.
Int J Pharm. 2000 Mar 10;196(2):211-3. doi: 10.1016/s0378-5173(99)00424-x.
Drug-loaded solid lipid nanoparticles (SLN) suitable for parenteral administration were freeze-dried. The lipid matrix Imwitor 900 (concentration, 2.5%) was stabilized with Lipoid E 80 and sodium glycocholate. The influence of different parameters of lyophilization like the protective effect of cryoprotectants, freezing velocity, and thermal treatment was investigated. The results of this study demonstrate that, by optimizing critical process parameters, i.v.-injectable SLN-dispersions can be freeze-dried, preserving their small particle size.
适合肠胃外给药的载药固体脂质纳米粒(SLN)被冻干。脂质基质Imwitor 900(浓度2.5%)用Lipoid E 80和甘胆酸钠进行稳定化处理。研究了冻干的不同参数如冷冻保护剂的保护作用、冷冻速度和热处理的影响。本研究结果表明,通过优化关键工艺参数,静脉注射用SLN分散体可以被冻干,并保持其小粒径。